サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1547723

エクソソームの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測

Global Exosomes Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日
ページ情報
英文 181 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
エクソソームの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測
出版日: 2024年07月01日
発行: Value Market Research
ページ情報: 英文 181 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

エクソソーム市場の世界需要は、2023年の1億6,974万米ドルから2032年には2億2,498万米ドル近くの市場規模に達すると推定され、調査期間2024～2032年のCAGRは3.18%です。

エクソソームとは、それを産生する細胞のタンパク質、RNA、DNAを含む細胞外小胞を指します。エクソソーム療法は、がんの早期発見に用いられる新しい治療法です。牛乳から抽出されたエクソソームは、乳がんや肺がんに対する治療分子の送達に主に使用されています。エクソソームは、高い生体適合性や本質的な長期循環性など、天然の物質輸送特性を備えているため、ドラッグデリバリーのためのビークルとして機能する大きな可能性を秘めています。エクソソームを介した細胞間コミュニケーションは、がん、炎症性疾患、神経変性疾患など、さまざまな疾患の病因に関与していると考えられています。

市場力学

エクソソームの単離と分析手順における技術的進歩とともに、世界中でがん患者の有病率が上昇していることが、予測期間にわたってエクソソーム市場を牽引する主要要因です。さらに、治療におけるエクソソームの高度な応用の増加、がんの早期診断に対する重点の高まりは、世界のエクソソーム市場の成長に大きく寄与しています。医療支出の増加と医療に関する意識の高まりは、エクソソーム市場の世界の成長にプラスの影響を与えます。さらに、主要企業の強力なパイプライン製品と相まって、民間と公的機関による腫瘍学の研究開発の増加は、今後数年間で市場に有利な機会を創出すると期待されています。

調査レポートは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、エクソソームの世界市場における各セグメントを包括的に評価することもできます。エクソソーム産業の成長と動向は、この調査に全体的なアプローチを記載しています。

市場セグメンテーション

本セクションでは、国別と地域別のセグメントに関する詳細なデータを提供することで、戦略担当者が各製品やサービスの対象層を特定し、今後のビジネス機会に役立てることができます。

地域分析

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおけるエクソソーム市場の現在と将来の需要を強調する地域展望をカバーします。さらに、著名な全地域における個々の用途セグメントの需要・推定・予測にも焦点を当てています。

ご要望がございましたら、弊社までご連絡ください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 エクソソーム-産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカー一覧
    • 主要原材料の価格動向
  • 潜在的バイヤー一覧
  • マーケティングチャネル
    • 直接マーケティング
    • 間接マーケティング
    • マーケティングチャネル発展動向

第5章 エクソソームの世界市場分析：製品別

  • 製品別概要
  • 実績データと予測データ
  • 製品別分析
  • キット・試薬
  • 器具
  • サービス

第6章 エクソソームの世界市場分析：ワークフロー別

  • ワークフロー別概要
  • 実績データと予測データ
  • ワークフロー別分析
  • 単離法（超遠心法、ビーズ上免疫捕捉法、沈殿法、濾過法、その他）
  • ダウンストリーム分析（フローサイトメトリーによる細胞表面マーカー分析、ブロッティング＆ELISAによるタンパク質分析、Ngs＆PcrによるRNA分析、質量分析によるプロテオーム分析、その他）

第7章 エクソソームの世界市場分析：用途別

  • 用途別概要
  • 実績データと予測データ
  • 用途別分析
  • がん
  • 神経変性疾患
  • 心血管疾患
  • 感染症
  • その他

第8章 エクソソームの世界市場分析：最終用途別

  • 最終用途別概要
  • 実績データと予測データ
  • 最終用途別分析
  • 製薬・バイオテクノロジー企業
  • 病院・診断センター
  • 学術・研究機関

第9章 エクソソームの世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米の売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第10章 エクソソーム企業の競合情勢

  • エクソソーム市場の競合
  • 提携・協力・契約
  • 合併・買収
  • 新製品上市
  • その他の開発

第11章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Danaher Corporation
  • Hologic Inc.
  • Fujifilm Holdings Corporation
  • Lonza
  • Miltenyi Biotec
  • Bio-Techne Corporation
  • QIAGEN
  • Thermo Fisher Scientific Inc.
  • Abcam Plc
  • RoosterBio Inc
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Kits & Reagents Market Sales By Geography (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Services Market Sales By Geography (USD MN)
  • Analysis By Workflow (USD MN)
  • Isolation Methods (Ultracentrifugation, Immunocapture On Beads, Precipitation, Filtration, Others) Market Sales By Geography (USD MN)
  • Downstream Analysis (Cell Surface Marker Analysis Using Flow Cytometry, Protein Analysis Using Blotting & Elisa, Rna Analysis With Ngs & Pcr, Proteomic Analysis Using Mass Spectroscopy, Others) Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Cancer Market Sales By Geography (USD MN)
  • Neurodegenerative Diseases Market Sales By Geography (USD MN)
  • Cardiovascular Diseases Market Sales By Geography (USD MN)
  • Infectious Diseases Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-Use (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales By Geography (USD MN)
  • Hospitals & Diagnostics Centers Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Global Exosomes Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Exosomes Report
  • Market Research Process
  • Market Research Methodology
  • Global Exosomes Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Workflow
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-Use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Kits & Reagents Market Sales By Geography (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Services Market Sales By Geography (USD MN)
  • Global Market Analysis By Workflow (USD MN)
  • Isolation Methods (Ultracentrifugation, Immunocapture On Beads, Precipitation, Filtration, Others) Market Sales By Geography (USD MN)
  • Downstream Analysis (Cell Surface Marker Analysis Using Flow Cytometry, Protein Analysis Using Blotting & Elisa, Rna Analysis With Ngs & Pcr, Proteomic Analysis Using Mass Spectroscopy, Others) Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Cancer Market Sales By Geography (USD MN)
  • Neurodegenerative Diseases Market Sales By Geography (USD MN)
  • Cardiovascular Diseases Market Sales By Geography (USD MN)
  • Infectious Diseases Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-Use (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales By Geography (USD MN)
  • Hospitals & Diagnostics Centers Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11213631

The global demand for Exosomes Market is presumed to reach the market size of nearly USD 224.98 Million by 2032 from USD 169.74 Million in 2023 with a CAGR of 3.18% under the study period 2024-2032.

Exosomes refer to an extracellular vesicle that contains protein, RNA, and DNA of the cells that produce them. Exosome therapy is the new treatment used in the early stage of cancer detection. Exosomes extracted from cow milk are majorly used to deliver therapeutic molecules against breast and lung cancers. Exosomes have huge potential to act like vehicles for drug delivery because they have natural material transportation properties such as high biocompatibility and intrinsic long-term circulation. Intercellular communication through exosomes supposed to be involved in the pathogenesis of a variety of disorders such as cancer, inflammatory and neurodegeneration diseases.

MARKET DYNAMICS

The rising prevalence of cancer cases across the globe, along with technological advancements in exosomes isolation and analytical procedures, are the major factors driving the exosomes market over the forecast period. Moreover, increasing advanced applications of exosomes in therapeutic and the rising emphasis on early diagnosis of cancer are highly contributing to the growth of the global exosomes market. The rising healthcare expenditure and growing awareness related to healthcare creates a positive impact on the growth of the exosomes market globally. Furthermore, increasing research and development in oncology by private and public institutions, coupled with strong pipeline products of key players, are expected to create a lucrative opportunity for the market in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Exosomes. The growth and trends of Exosomes industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Exosomes market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Kits & Reagents
  • Instruments
  • Services

By Workflow

  • Isolation Methods (Ultracentrifugation, Immunocapture On Beads, Precipitation, Filtration, Others)
  • Downstream Analysis (Cell Surface Marker Analysis Using Flow Cytometry, Protein Analysis Using Blotting & Elisa, Rna Analysis With Ngs & Pcr, Proteomic Analysis Using Mass Spectroscopy, Others)

By Application

  • Cancer
  • Neurodegenerative Diseases
  • Cardiovascular Diseases
  • Infectious Diseases
  • Others

By End-Use

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostics Centers
  • Academic & Research Institutes

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Exosomes market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Exosomes market include Danaher Corporation, Hologic Inc., Fujifilm Holdings Corporation, Lonza, Miltenyi Biotec, Bio-Techne Corporation, QIAGEN, Thermo Fisher Scientific Inc., Abcam Plc, RoosterBio Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. EXOSOMES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Workflow
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End-Use
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL EXOSOMES MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Product
  • 5.4. Kits & Reagents Historic and Forecast Sales By Regions
  • 5.5. Instruments Historic and Forecast Sales By Regions
  • 5.6. Services Historic and Forecast Sales By Regions

6. GLOBAL EXOSOMES MARKET ANALYSIS BY WORKFLOW

  • 6.1. Overview By Workflow
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Workflow
  • 6.4. Isolation Methods (Ultracentrifugation, Immunocapture On Beads, Precipitation, Filtration, Others) Historic and Forecast Sales By Regions
  • 6.5. Downstream Analysis (Cell Surface Marker Analysis Using Flow Cytometry, Protein Analysis Using Blotting & Elisa, Rna Analysis With Ngs & Pcr, Proteomic Analysis Using Mass Spectroscopy, Others) Historic and Forecast Sales By Regions

7. GLOBAL EXOSOMES MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Application
  • 7.4. Cancer Historic and Forecast Sales By Regions
  • 7.5. Neurodegenerative Diseases Historic and Forecast Sales By Regions
  • 7.6. Cardiovascular Diseases Historic and Forecast Sales By Regions
  • 7.7. Infectious Diseases Historic and Forecast Sales By Regions
  • 7.8. Others Historic and Forecast Sales By Regions

8. GLOBAL EXOSOMES MARKET ANALYSIS BY END-USE

  • 8.1. Overview By End-Use
  • 8.2. Historical and Forecast Data
  • 8.3. Analysis By End-Use
  • 8.4. Pharmaceutical & Biotechnology Companies Historic and Forecast Sales By Regions
  • 8.5. Hospitals & Diagnostics Centers Historic and Forecast Sales By Regions
  • 8.6. Academic & Research Institutes Historic and Forecast Sales By Regions

9. GLOBAL EXOSOMES MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE EXOSOMES COMPANIES

  • 10.1. Exosomes Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF EXOSOMES INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Danaher Corporation
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Hologic Inc.
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Fujifilm Holdings Corporation
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Lonza
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Miltenyi Biotec
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Bio-Techne Corporation
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. QIAGEN
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Thermo Fisher Scientific Inc.
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Abcam Plc
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. RoosterBio Inc
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies